These PD-L1 expressing BVs have the potential to foster an immunosuppressive tumour microenvironment by inducing regulatory T cells (Treg) [42–44], which we have previously shown to confer a poor outcome in breast cancer [45]. The gene discussed is CD274; the disease is neoplasm.